A detailed history of Fidelity D & D Bancorp Inc transactions in Amgen Inc stock. As of the latest transaction made, Fidelity D & D Bancorp Inc holds 890 shares of AMGN stock, worth $262,131. This represents 0.21% of its overall portfolio holdings.

Number of Shares
890
Previous 935 4.81%
Holding current value
$262,131
Previous $266 Million 4.61%
% of portfolio
0.21%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $11,823 - $14,368
-45 Reduced 4.81%
890 $278 Million
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $8,872 - $10,710
-33 Reduced 3.41%
935 $266 Million
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $19,177 - $21,634
-75 Reduced 7.19%
968 $279 Million
Q3 2023

Nov 30, 2023

BUY
$218.65 - $271.46 $228,051 - $283,132
1,043 New
1,043 $280 Million
Q1 2023

Apr 16, 2024

SELL
$225.79 - $275.2 $7,451 - $9,081
-33 Reduced 3.41%
935 $266 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fidelity D & D Bancorp Inc Portfolio

Follow Fidelity D & D Bancorp Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelity D & D Bancorp Inc, based on Form 13F filings with the SEC.

News

Stay updated on Fidelity D & D Bancorp Inc with notifications on news.